PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China
· Delayed Price · Currency is CNY 40.85
-0.15 (-0.37%)
Mar 9, 2026, 4:00 PM EDT
SHE:301230 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,619 | 3,510 | 3,853 | 4,107 | - | - | Upgrade
|
| Market Cap Growth | 24.77% | -8.90% | -6.18% | - | - | - | Upgrade
|
| Enterprise Value | 5,491 | 3,336 | 3,484 | 4,132 | - | - | Upgrade
|
| Last Close Price | 40.85 | 25.17 | 26.76 | 28.29 | - | - | Upgrade
|
| PE Ratio | 159.70 | 205.47 | 102.42 | 61.13 | - | - | Upgrade
|
| Forward PE | - | 52.62 | 30.60 | - | - | - | Upgrade
|
| PS Ratio | 8.42 | 6.45 | 7.87 | 8.57 | - | - | Upgrade
|
| PB Ratio | 5.48 | 3.40 | 3.45 | 3.69 | - | - | Upgrade
|
| P/TBV Ratio | 5.52 | 3.43 | 3.48 | 3.72 | - | - | Upgrade
|
| P/OCF Ratio | 39.49 | 43.41 | 184.72 | 41.36 | - | - | Upgrade
|
| EV/Sales Ratio | 8.23 | 6.13 | 7.12 | 8.63 | - | - | Upgrade
|
| EV/EBITDA Ratio | 72.44 | 196.19 | 73.49 | 53.94 | - | - | Upgrade
|
| EV/EBIT Ratio | 237.31 | - | 130.77 | 68.58 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.18 | 0.19 | 0.09 | 0.31 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 2.31 | 4.55 | 3.32 | 1.13 | 0.98 | 0.31 | Upgrade
|
| Debt / FCF Ratio | 2.38 | - | - | - | 8.33 | 1.08 | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.15 | -0.31 | -0.61 | -0.01 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.41 | -9.36 | -7.25 | -8.88 | -0.05 | -1.22 | Upgrade
|
| Net Debt / FCF Ratio | -1.73 | 5.58 | 1.51 | 27.58 | -0.37 | -4.23 | Upgrade
|
| Asset Turnover | 0.50 | 0.39 | 0.35 | 0.52 | 0.99 | 0.89 | Upgrade
|
| Inventory Turnover | 6.51 | 6.35 | 6.23 | 6.22 | 5.16 | 3.42 | Upgrade
|
| Quick Ratio | 3.24 | 3.55 | 3.34 | 8.61 | 1.60 | 1.83 | Upgrade
|
| Current Ratio | 4.08 | 4.42 | 3.82 | 9.28 | 2.15 | 2.78 | Upgrade
|
| Return on Equity (ROE) | 3.53% | 1.59% | 3.37% | 9.19% | 24.06% | 21.02% | Upgrade
|
| Return on Assets (ROA) | 1.09% | -0.40% | 1.19% | 4.05% | 11.97% | 11.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.58% | -1.08% | 4.42% | 14.30% | 28.64% | 33.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | -0.70% | 2.10% | 5.00% | 20.30% | 22.70% | Upgrade
|
| Earnings Yield | 0.65% | 0.49% | 0.98% | 1.64% | - | - | Upgrade
|
| FCF Yield | 1.31% | -0.81% | -5.90% | -0.60% | - | - | Upgrade
|
| Dividend Yield | 1.22% | 1.71% | 0.95% | 0.97% | - | - | Upgrade
|
| Payout Ratio | 162.71% | 288.43% | 103.18% | 1.17% | 1.06% | 120.90% | Upgrade
|
| Buyback Yield / Dilution | -3.34% | -2.17% | -26.04% | -5.66% | -1.58% | -1.86% | Upgrade
|
| Total Shareholder Return | -2.12% | -0.46% | -25.10% | -4.69% | -1.58% | -1.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.